Volpara Health Technologies (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies (ASX: VHT)
Latest News
Share Market News
3 ASX shares using AI to help supercharge profits
Cheap Shares
How I'm aiming to find under-the-radar cheap ASX shares right now
Opinions
Top ASX shares under $3 to buy in July 2023
Growth Shares
3 ASX growth shares I think are monsters in the making
Healthcare Shares
Here's why the Volpara Health share price is leaping 7% today
Growth Shares
I rate these strong ASX growth shares as buys for FY24 and beyond
Investing Strategies
Got $20k in savings? Here's how I'd aim to turn it into $100k with ASX shares
Technology Shares
Should I be buying ASX artificial intelligence shares right now?
Technology Shares
2 under-the-radar ASX tech shares that could benefit from the AI boom
Share Market News
Are we in the middle of a once-in-a-lifetime chance to buy cheap ASX shares?
Opinions
This is my #1 ASX growth share to buy right now
How to invest
Could ASX shares turn a $10,000 investment into $2,000,000?
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.